Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Development and validation of human psoriatic skin equivalents.

Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, Schalkwijk J.

Am J Pathol. 2008 Sep;173(3):815-23. doi: 10.2353/ajpath.2008.080173. Epub 2008 Jul 31.

2.

Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.

Van Ruissen F, de Jongh GJ, Zeeuwen PL, Van Erp PE, Madsen P, Schalkwijk J.

J Cell Physiol. 1996 Aug;168(2):442-52.

PMID:
8707880
3.

The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.

Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.

Arch Dermatol Res. 2008 Jan;300(1):37-45. Epub 2007 Oct 25.

PMID:
17960400
5.

Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.

Kamsteeg M, Bergers M, de Boer R, Zeeuwen PL, Hato SV, Schalkwijk J, Tjabringa GS.

Am J Pathol. 2011 May;178(5):2091-9. doi: 10.1016/j.ajpath.2011.01.037.

6.

RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).

Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I.

Br J Dermatol. 1998 Jan;138(1):63-70.

PMID:
9536224
7.

SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.

Alkemade JA, Molhuizen HO, Ponec M, Kempenaar JA, Zeeuwen PL, de Jongh GJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC, Schalkwijk J.

J Cell Sci. 1994 Aug;107 ( Pt 8):2335-42.

8.

A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes.

Pol A, Bergers M, van Ruissen F, Pfundt R, Schalkwijk J.

Skin Pharmacol Appl Skin Physiol. 2002 Jul-Aug;15(4):252-61.

PMID:
12218287
9.

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

Nickoloff BJ, Karabin GD, Barker JN, Griffiths CE, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM.

Am J Pathol. 1991 Jan;138(1):129-40.

10.
11.
12.

TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway.

Pfundt R, Wingens M, Bergers M, Zweers M, Frenken M, Schalkwijk J.

Arch Dermatol Res. 2000 Apr;292(4):180-7.

PMID:
10836611
13.
14.

Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.

Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN.

Br J Dermatol. 1995 Oct;133(4):501-11.

PMID:
7577575
15.
16.
17.

A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.

Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V.

J Exp Med. 1996 Nov 1;184(5):2007-12.

18.
19.

Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha.

Löntz W, Sirsjö A, Liu W, Lindberg M, Rollman O, Törmä H.

Free Radic Biol Med. 1995 Feb;18(2):349-55.

PMID:
7744320
20.

The development and characterization of an in vitro model of psoriasis.

Barker CL, McHale MT, Gillies AK, Waller J, Pearce DM, Osborne J, Hutchinson PE, Smith GM, Pringle JH.

J Invest Dermatol. 2004 Nov;123(5):892-901.

Items per page

Supplemental Content

Write to the Help Desk